Li, Q., Guo, R., Zhao, C., Chen, X., Wang, H., & Shen, C. (2025). End Plate Chondrocyte-Derived Exosomal miR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway through the miR-133a-3p/MAML1 Axis. Molecular Pharmaceutics, 22(3), 1262-1279. https://doi.org/10.1021/acs.molpharmaceut.4c00962
Chicago-referens (17:e uppl.)Li, Qiuwei, Ruocheng Guo, Chenhao Zhao, Xuewu Chen, Hong Wang, och Cailiang Shen. "End Plate Chondrocyte-Derived Exosomal MiR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway Through the MiR-133a-3p/MAML1 Axis." Molecular Pharmaceutics 22, no. 3 (2025): 1262-1279. https://doi.org/10.1021/acs.molpharmaceut.4c00962.
MLA-referens (9:e uppl.)Li, Qiuwei, et al. "End Plate Chondrocyte-Derived Exosomal MiR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway Through the MiR-133a-3p/MAML1 Axis." Molecular Pharmaceutics, vol. 22, no. 3, 2025, pp. 1262-1279, https://doi.org/10.1021/acs.molpharmaceut.4c00962.
